SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $533K invested in Salarius Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$208K
2
+$114K
3
+$31K
4
Deutsche Bank
Deutsche Bank
Germany
+$10K
5
UBS Group
UBS Group
Switzerland
+$8K

Top Sellers

1
-$5K
2
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$208K
2
$155K
3
$54K
4
$31K
5
$27K
6
$12K
7
$10K
8
$8K
9
$8K
10
$8K
11
$6K
12
$2K
13
$1K
14
$1K
15
$1K
16
$1K